Kevin D. Courtney, Ph.D.
Affiliations: | University of Texas Southwestern Medical Center, Dallas, TX, United States | ||
2001 | Duke University, Durham, NC |
Area:
Molecular Biology, Cell BiologyWebsite:
https://profiles.utsouthwestern.edu/profile/131906/kevin-courtney.htmlGoogle:
"Kevin Courtney"Mean distance: 26716.5
Parents
Sign in to add mentorAnn M. Pendergast | grad student | 2001 | Duke | |
(Characterization of the Abl -interactor (Abi) proteins.) | ||||
Lewis C. Cantley | post-doc | Dana-Farber Cancer Institute (Chemistry Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Davdison SM, Schmidt DR, Heyman JE, et al. (2022) Pyruvate kinase M1 suppresses development and progression of prostate adenocarcinoma. Cancer Research |
Brugarolas J, Courtney KD, Ma Y, et al. (2019) HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor in Clear Cell Renal Cell Carcinoma Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Desai NB, Courtney K, Subramaniam RM, et al. (2019) Salvage Radiotherapy for Nodal Oligorecurrent Prostate Cancer: A Step Towards Predictive Criteria for Metastasis-Directed Therapy in Prostate Cancer? European Urology |
Zhang Y, Schoenhals J, Christie A, et al. (2019) Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. International Journal of Radiation Oncology, Biology, Physics |
Zhang Y, Schoenhals J, Christie A, et al. (2019) Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer. Journal of Clinical Oncology. 37: 599-599 |
Courtney KD, Bezwada D, Mashimo T, et al. (2018) Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo. Cell Metabolism |
Kobayashi M, Chung JS, Beg M, et al. (2018) Blocking monocytic myeloid-derived suppressor cell function via anti-DC-HIL/GPNMB antibody restores the in vitro integrity of T-cells from cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Wang JS, Barve MA, Chiorean EG, et al. (2018) Interim results from a phase 1 trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumors. Journal of Clinical Oncology. 36: 2560-2560 |
Tumati V, Jackson WC, Abugharib AE, et al. (2017) Natural History of 'Second' Biochemical Failure Following Salvage Radiation Therapy for Prostate Cancer: A Multi-Institution Study. Bju International |
Li J, Alyamani M, Zhang A, et al. (2017) Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer. Elife. 6 |